Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
复制标题
DOI:
10.1158/2159-8290.cd-16-0607
复制
发表时间:
2016-12
期刊:
影响因子:
28.2
通讯作者:
Lengyel E
中科院分区:
文献类型:
--
作者:
Eckert MA;Pan S;Hernandez KM;Loth RM;Andrade J;Volchenboum SL;Faber P;Montag A;Lastra R;Peter ME;Yamada SD;Lengyel E
Accumulating evidence has supported the fallopian tube rather than the ovary as the origin for high grade serous ovarian cancer (HGSOC). To understand the relationship between putative precursor lesions and metastatic tumors, we performed whole exome sequencing on specimens from eight HGSOC patient progression series consisting of serous tubal intraepithelial carcinomas (STIC), invasive fallopian tube lesions, invasive ovarian lesions, and omental metastases. Integration of copy number and somatic mutations revealed patient-specific patterns with similar mutational signatures and copy number variation profiles across all anatomic sites, suggesting that genomic instability is an early event in HGSOC. Phylogenetic analyses supported STIC as precursor lesions in half of our patient cohort, but also identified STIC as metastases in two patients. Ex vivo assays revealed that HGSOC spheroids can implant in the fallopian tube epithelium and mimic STIC lesions. That STIC may represent metastases calls into question the assumption that STIC are always indicative of primary fallopian tube cancers.